Second Primary Cancers Occurring after I-125 Brachytherapy as Monotherapy for Early Prostate Cancer

Dall'Era, 2012, Active surveillance for prostate cancer: a systematic review of the literature, Eur Urol, 62, 976, 10.1016/j.eururo.2012.05.072 Center, 2012, International variation in prostate cancer incidence and mortality rates, Eur Urol, 61, 1079, 10.1016/j.eururo.2012.02.054 Draisma, 2003, Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer, J Natl Cancer Inst, 95, 868, 10.1093/jnci/95.12.868 Andriole, 2009, Mortality results from a randomized prostate-cancer screening trial, N Engl J Med, 360, 1310, 10.1056/NEJMoa0810696 Grimm, 2012, Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group, BJU Int, 109, 22, 10.1111/j.1464-410X.2011.10827.x Brenner, 2000, Second malignancies in prostate carcinoma patients after radiotherapy compared with surgery, Cancer, 88, 398, 10.1002/(SICI)1097-0142(20000115)88:2<398::AID-CNCR22>3.0.CO;2-V Hinnen, 2011, Prostate brachytherapy and second primary cancer risk: a competitive risk analysis, J Clin Oncol, 29, 4510, 10.1200/JCO.2011.35.0991 Abdel-Wahab, 2008, Second primary cancer after radiotherapy for prostate cancer: a SEER analysis of brachytherapy versus external beam radiotherapy, Int J Radiat Oncol Biol Phys, 72, 58, 10.1016/j.ijrobp.2007.12.043 Grimm, 1994, Ultrasound guided transperineal implantation of iodine 125 and palladium 103 for the treatment of early stage prostate cancer. Technique concepts in planning, operative techniques and evaluation, Urol Clin N Am, 2, 113 Liauw, 2006, Second malignancies after prostate brachytherapy: incidence of bladder and colorectal cancers in patients with 15 years of potential follow-up, Int J Radiat Oncol Biol Phys, 66, 669, 10.1016/j.ijrobp.2006.05.016 Moon, 2006, Cancer incidence after localized therapy for prostate cancer, Cancer, 107, 991, 10.1002/cncr.22083 Reddy, 2010, Second malignancies after definitive radiotherapy for prostate cancer, Brachytherapy, 9, S78, 10.1016/j.brachy.2010.02.131 Zelefsky, 2012, Secondary cancers after intensity-modulated radiotherapy, brachytherapy and radical prostatectomy for the treatment of prostate cancer: incidence and cause-specific survival outcomes according to the initial treatment intervention, BJU Int, 110, 1696, 10.1111/j.1464-410X.2012.11385.x Gutman, 2006, Temporal relationship between prostate brachytherapy and the diagnosis of colorectal cancer, Int J Radiat Oncol Biol Phys, 66, 48, 10.1016/j.ijrobp.2006.03.029 Huang, 2011, Analysis of second malignancies after modern radiotherapy versus prostatectomy for localized prostate cancer, Radiother Oncol, 98, 81, 10.1016/j.radonc.2010.09.012 Swartz, 2010, Brachytherapy for localized prostate cancer: outcome results with 10 years minimum follow-up, J Urol, 1, e675 Chadwick, 2011, LDR brachytherapy in men <55 yrs is effective and well tolerated, BJU Int, 108, 34 Wilcox, 2011, Thirteen-year biochemical progression free survival in clinical stage T1-T2 prostate cancer patients treated with permanent seed implantation: Baylor University Medical Center experience, Brachytherapy, 10, S53, 10.1016/j.brachy.2011.02.091